What is Appello Pharmaceuticals?
Appello Pharmaceuticals is dedicated to addressing the growing global challenge of neurological disorders by advancing pharmaceutical research and development. The company focuses on translating recent scientific discoveries about the human brain into innovative drug therapies aimed at improving the lives of patients with neurological conditions. With a commitment to driving a paradigm shift in treatment, Appello positions itself as a global leader in the field. Their efforts are particularly targeted towards patients suffering from various neurologic diseases, indicating a strong focus on unmet medical needs within this complex therapeutic area.
How much funding has Appello Pharmaceuticals raised?
Appello Pharmaceuticals has raised a total of $10.5M across 1 funding round:
Series A
$10.5M
Series A (2020): $10.5M with participation from Deerfield Communications Inc and Mountain Group Capital , LLC
Key Investors in Appello Pharmaceuticals
Deerfield Communications Inc
Deerfield Communications Inc is likely a venture capital firm specializing in healthcare and life sciences, providing strategic capital for companies in the pharmaceutical and biotechnology sectors.
Mountain Group Capital , LLC
Mountain Group Capital, LLC appears to be an investment firm focused on providing significant financial backing to companies, potentially with a specialization in growth-stage enterprises within the pharmaceutical industry.
What's next for Appello Pharmaceuticals?
The recent major strategic investment signifies a crucial phase for Appello Pharmaceuticals, likely enabling accelerated clinical trials, expanded research initiatives, and potential market entry for its novel drug therapies. This enterprise-level funding provides the necessary capital to navigate the rigorous drug development process and solidify its position as a leader in neurological treatments. The company's trajectory suggests a focus on scaling operations and further innovation in addressing debilitating neurological conditions.
See full Appello Pharmaceuticals company page
